Enzyme drug used for acute leukemia treatment:

Questions 265

ATI RN

ATI RN Test Bank

Pharmacology Across the Lifespan ATI Questions

Question 1 of 5

Enzyme drug used for acute leukemia treatment:

Correct Answer: B

Rationale: In the treatment of acute leukemia, the enzyme drug used is Asparaginase. Asparaginase works by depleting levels of asparagine in the blood, which is essential for leukemia cells to grow and survive. By depriving the cancer cells of this vital amino acid, their growth is inhibited, leading to cell death. Option A, Dihydrofolate reductase, is not the correct answer because it is an enzyme targeted by drugs like methotrexate for the treatment of various cancers and autoimmune diseases, not specifically acute leukemia. Option C, Aromatase, is an enzyme targeted in hormone-positive breast cancer treatment to inhibit estrogen production, and it is not used in acute leukemia therapy. Option D, DNA gyrase, is an enzyme targeted by antibiotics like fluoroquinolones to inhibit bacterial DNA replication, and it is not relevant to the treatment of acute leukemia. Understanding the mechanism of action of each drug is crucial for healthcare professionals to make informed decisions in patient care. In the context of pharmacology across the lifespan, knowing the appropriate enzyme drug for specific conditions is essential for providing safe and effective treatment, especially in vulnerable populations like pediatric patients with acute leukemia.

Question 2 of 5

Which of the following is false regarding Burkitt’s lymphoma?

Correct Answer: A

Rationale: Burkitt’s lymphoma involves a t(8;14) translocation of the c-myc gene, not chromosome 18 (A is false). It presents with abdominal involvement in HIV (B, true), is common in African children with EBV and malaria (C, true), shows a 'starry sky' pattern (D, true), and is treated with cyclophosphamide/vincristine (E, true). The correct translocation is 8;14, making A the false statement.

Question 3 of 5

A 36 year old woman presented with weakness, lassitude and feeling easily tired. Her bone marrow aspirate showed 15% myeloblasts and reduced erythropoiesis. The most likely cause is

Correct Answer: A

Rationale: Weakness, fatigue, 15% myeloblasts, and reduced erythropoiesis suggest acute myeloid leukemia (AML, A), defined by >20% blasts (15% is borderline but fits with progression). ALL (B) has lymphoblasts, myelofibrosis (C) shows fibrosis, myelodysplastic syndrome (D) has <20% blasts typically, and CML (E) has granulocytes—AML aligns best.

Question 4 of 5

The vector of visceral leishmaniasis has geographical variations. In the Asian region the main vector is

Correct Answer: A

Rationale: The correct answer is A) Phlebotomus species as the main vector of visceral leishmaniasis in the Asian region. Phlebotomus species are sandflies known to transmit the parasite responsible for causing visceral leishmaniasis. These sandflies are prevalent in the Asian region and are specifically adapted to transmit the Leishmania parasite to humans. Option B) Lutzomyia species is more commonly associated with transmitting leishmaniasis in the Americas, not in the Asian region where Phlebotomus species are the primary vectors. Option C) Anopheles species are known vectors of malaria, not leishmaniasis. Option D) Mansonia species are primarily associated with transmitting diseases like filariasis, not leishmaniasis. Understanding the specific vectors of diseases is crucial in pharmacology to develop effective prevention and treatment strategies. By knowing the geographical variations in vectors, healthcare providers can implement targeted interventions to control the spread of diseases like leishmaniasis. This knowledge is essential for pharmacology students to grasp the epidemiology of diseases and make informed decisions in clinical practice.

Question 5 of 5

Spermatogenesis:

Correct Answer: B

Rationale: In the context of Pharmacology Across the Lifespan, understanding spermatogenesis is crucial as it relates to the effects of medications on the male reproductive system. The correct answer is B) begins at puberty. Spermatogenesis is the process of sperm cell development in the testes, which begins at puberty when hormonal changes trigger the maturation of sperm cells. Option A) occurs at the level of the straight tubules is incorrect because spermatogenesis occurs in the seminiferous tubules, not the straight tubules. Option C) is stimulated by the LH is incorrect because LH (luteinizing hormone) stimulates Leydig cells to produce testosterone, which supports spermatogenesis but does not directly stimulate the process. Option D) is stimulated by testosterone is incorrect because while testosterone is essential for spermatogenesis, it is not the direct stimulant for the process to begin. Educationally, understanding spermatogenesis is essential for healthcare professionals to comprehend the effects of medications on male fertility and reproductive health. By grasping the timeline and hormonal regulation of spermatogenesis, healthcare providers can make informed decisions regarding drug therapies that may impact male reproductive function.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions